Baldwin Wealth Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-26
Closed -$4K – 839
2022
Q3
$4K Hold
26
– – ﹤0.01% 586
2022
Q2
$5K Hold
26
– – ﹤0.01% 596
2022
Q1
$4K Buy
26
+1
+4% +$135 ﹤0.01% 621
2021
Q4
$4K Hold
25
– – ﹤0.01% 584
2021
Q3
$4K Hold
25
– – ﹤0.01% 597
2021
Q2
$4K Hold
25
– – ﹤0.01% 603
2021
Q1
$3K Hold
25
– – ﹤0.01% 589
2020
Q4
$4K Hold
25
– – ﹤0.01% 508
2020
Q3
$5K Sell
25
-250
-91% -$41.9K ﹤0.01% 476
2020
Q2
$47K Buy
275
+250
+1,000% +$37.3K 0.01% 302
2020
Q1
$3K Hold
25
– – ﹤0.01% 507
2019
Q4
$3K Buy
+25
New +$2.65K ﹤0.01% 509

Other funds holding SGEN

Baldwin Wealth Partners's SGEN Position: Q4 2022 in Review

Baldwin Wealth Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2022, closing a stake of 26 shares — an estimated $4K sold.

Baldwin Wealth Partners first reported a position in SGEN in Q4 2019 and held it in 12 quarters. The position peaked at $47K in Q2 2020. 537 funds tracked by Wall St. Rank hold SGEN as of Q4 2022.

  • Baldwin Wealth Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Baldwin Wealth Partners sold 26 Seagen Inc. Common Stock shares in Q4 2022, an estimated $4K.
  • Baldwin Wealth Partners first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Baldwin Wealth Partners's Seagen Inc. Common Stock position peaked at $47K in Q2 2020.
  • 537 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2022.

Based on Baldwin Wealth Partners's 13F filing for Q4 2022, filed 27 Jan 2023.